Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Brigham and Women's Hospital5,154 enrolled

Overview

Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.

The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additionally, we will assess outcomes according to differences in geographic and institutional parameters.

Study Type

OBSERVATIONAL

Enrollment

5,154

Conditions

Coronavirus Infection

Interventions

No interventionOTHER

Observational

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria (each of the following): 1. Adults (aged ≥18 years) 2. Laboratory-confirmed diagnosis of COVID-19 3. Hospitalized in the ICU for illness related to COVID-19 Exclusion Criteria: -None

Locations (1)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

28-Day Mortality

Time frame: 28-days from the day of ICU admission

Secondary Outcomes

60-Day Mortality

Time frame: 60-days from the day of ICU admission

90-Day Mortality

Time frame: 90-days from the day of ICU admission

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.